Antiviral therapy and outcomes in hospitalized patients with influenza

Clinical Infectious Diseases

Volumn 46, Issue 10, 2008, Pages 1628-1629

  Chan Tack, Kirk M ^a   Murray, Jeffrey S ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; CLINICAL ASSESSMENT; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFLUENZA; LETTER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STANDARD; TREATMENT OUTCOME; VIRUS REPLICATION; VIRUS TITRATION; NOTE;

ANTIVIRAL AGENTS; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; TREATMENT OUTCOME;

EID: 43249113399     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/587751     Document Type: Letter

References (5)

1. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:1568-75.
2. Hayden FG, Pavia AT. Antiviral management of seasonal influenza. J Infect Dis 2006; 194(Suppl 2):S119-26.
3. Fine MJ, Hough LJ, Medsger AR, et al. The hospital admission decision for patients with community-acquired pneumonia: results from the pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1997; 157:36-44.
4. ClinicalTrials.gov. Evaluation of the efficacy and safety of peramivir in adults with acute serious or potentially life-threatening influenza. Available at: http://www.clinicaltrials.gov/. Accessed 14 December 2007.
5. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39:1300-6.